相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota
Yi Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2023)
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants
Deborah A. Hall et al.
NATURE COMMUNICATIONS (2023)
Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids
Maria Elisa Caetano-Silva et al.
SCIENTIFIC REPORTS (2023)
Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease
Szu-Ju Chen et al.
NEUROLOGY (2022)
Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease
Szu-Ju Chen et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease
Hiroshi Nishiwaki et al.
NPJ PARKINSONS DISEASE (2022)
Gut microbiota in dementia with Lewy bodies
Hiroshi Nishiwaki et al.
NPJ PARKINSONS DISEASE (2022)
Examination of Abnormal Alpha-synuclein Aggregates in the Enteric Neural Plexus in Patients with Ulcerative Colitis
Noriaki Gibo et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2022)
Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites
Xiaowu Bai et al.
GUT (2022)
Inflammation and immune dysfunction in Parkinson disease
Malu Gamez Tansey et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics
Ai Huey Tan et al.
ANNALS OF NEUROLOGY (2021)
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Allison Agus et al.
GUT (2021)
Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP+-induced Parkinson's disease
Huiping Qi et al.
NEUROSCIENCE LETTERS (2021)
Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes
Sarah Vascellari et al.
BIOMOLECULES (2021)
Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
Stefan Milde et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Alterations of gut microbiota and metabolome with Parkinson's disease
Zhenzhen Yan et al.
MICROBIAL PATHOGENESIS (2021)
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease
Velma T. E. Aho et al.
MOLECULAR NEURODEGENERATION (2021)
The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview
Julia Casani-Cubel et al.
METABOLITES (2021)
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease?
Mary K. Herrick et al.
NPJ PARKINSONS DISEASE (2021)
Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation
Stefano Romano et al.
NPJ PARKINSONS DISEASE (2021)
Blue poo: impact of gut transit time on the gut microbiome using a novel marker
Francesco Asnicar et al.
GUT (2021)
Pesticides and Parkinson's disease: Current and future perspective
Md Shahidul Islam et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2021)
Parkinson's Disease and Gut Microbiota
Masaaki Hirayama et al.
ANNALS OF NUTRITION AND METABOLISM (2021)
beta-adrenoreceptors and the risk of Parkinson's disease
Franziska Hopfner et al.
LANCET NEUROLOGY (2020)
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study
Jacob Horsager et al.
BRAIN (2020)
Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease
Yiwei Qian et al.
BRAIN (2020)
Meta-Analysisof Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki et al.
MOVEMENT DISORDERS (2020)
Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease
Sarah Vascellari et al.
MSYSTEMS (2020)
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
Hiroshi Nishiwaki et al.
MSYSTEMS (2020)
The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis
Feng Zhu et al.
DIGESTIVE AND LIVER DISEASE (2019)
Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway
John P. Haran et al.
MBIO (2019)
Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial
Y. Kobayashi et al.
BENEFICIAL MICROBES (2019)
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease
Chin-Hsien Lin et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Velma T. E. Aho et al.
EBIOMEDICINE (2019)
The gut microbiota perspective for interventions in MS
Magdalena Zoledziewska
AUTOIMMUNITY REVIEWS (2019)
Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study
Seona Park et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Dementia with Lewy bodies: an update and outlook
Tiago Fleming Outeiro et al.
MOLECULAR NEURODEGENERATION (2019)
The Nasal and Gut Microbiome in Parkinson's Disease and Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Anna Heintz-Buschart et al.
MOVEMENT DISORDERS (2018)
A survey of subjective constipation in Parkinson's disease patients in shanghai and literature review
Jing Gan et al.
BMC NEUROLOGY (2018)
Gut Microbiota is Altered in Patients with Alzheimer's Disease
Zhen-Qian Zhuang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Intestinal microbiota impact sepsis associated encephalopathy via the vagus nerve
Suyan Li et al.
NEUROSCIENCE LETTERS (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice Model
Guangxin Chen et al.
EBIOMEDICINE (2018)
A Neural Circuit for Gut-Induced Reward
Wenfei Han et al.
CELL (2018)
Appendectomy and Risk of Parkinson's Disease in Two Large Prospective Cohorts of Men and Women
Natalia Palacios et al.
MOVEMENT DISORDERS (2018)
Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin et al.
PARKINSONISM & RELATED DISORDERS (2018)
A gut-brain neural circuit for nutrient sensory transduction
Melanie Maya Kaelberer et al.
SCIENCE (2018)
The vermiform appendix impacts the risk of developing Parkinson's disease
Bryan A. Killinger et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
Ethan Stolzenberg et al.
JOURNAL OF INNATE IMMUNITY (2017)
Akkermansia muciniphila and its role in regulating host functions
Muriel Derrien et al.
MICROBIAL PATHOGENESIS (2017)
Vagotomy and Parkinson disease A Swedish register-based matched-cohort study
Bojing Liu et al.
NEUROLOGY (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Decreased intestinal acetylcholinesterase in early Parkinson disease
Tatyana D. Fedorova et al.
NEUROLOGY (2017)
Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers
Tetsuya Maeda et al.
PARKINSONISM & RELATED DISORDERS (2017)
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
Tomomi Minato et al.
PLOS ONE (2017)
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients
J. R. Bedarf et al.
GENOME MEDICINE (2017)
Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages
Wan-Kyu Ko et al.
PLOS ONE (2017)
Gut microbiota in Parkinson disease in a northern German cohort
Franziska Hopfner et al.
BRAIN RESEARCH (2017)
α-Synuclein in gut endocrine cells and its implications for Parkinson's disease
Rashmi Chandra et al.
JCI INSIGHT (2017)
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Toshiki Uchihara et al.
ACTA NEUROPATHOLOGICA (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Ara Koh et al.
CELL (2016)
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
Mahesh S. Desai et al.
CELL (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
Jun Chen et al.
GENOME MEDICINE (2016)
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
Changyoun Kim et al.
SCIENTIFIC REPORTS (2016)
Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Shu G. Chen et al.
SCIENTIFIC REPORTS (2016)
Vagotomy and Subsequent Risk of Parkinson's Disease
Elisabeth Svensson et al.
ANNALS OF NEUROLOGY (2015)
Quantitative Imaging of Gut Microbiota Spatial Organization
Kristen A. Earle et al.
CELL HOST & MICROBE (2015)
Host microbiota constantly control maturation and function of microglia in the CNS
Daniel Erny et al.
NATURE NEUROSCIENCE (2015)
UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2G2019S carriers and in vivo
Heather Mortiboys et al.
NEUROLOGY (2015)
Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET
Trine Gjerloff et al.
BRAIN (2015)
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease
Satoru Hasegawa et al.
PLOS ONE (2015)
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease
David Hilton et al.
ACTA NEUROPATHOLOGICA (2014)
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
Filipe De Vadder et al.
CELL (2014)
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
Nagendra Singh et al.
IMMUNITY (2014)
Smoking Cessation Alters Intestinal Microbiota: Insights from Quantitative Investigations on Human Fecal Samples Using FISH
Luc Biedermann et al.
INFLAMMATORY BOWEL DISEASES (2014)
Alpha-Synuclein in the Appendiceal Mucosa of Neurologically Intact Subjects
Madison T. Gray et al.
MOVEMENT DISORDERS (2014)
Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson's Disease
Leo P. Kelly et al.
MOVEMENT DISORDERS (2014)
Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats
Rohit Bisht et al.
NEUROTOXICOLOGY (2014)
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Gary Frost et al.
NATURE COMMUNICATIONS (2014)
Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications
Honglei Chen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2013)
Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon
Ja-Young Lee et al.
JOURNAL OF LIPID RESEARCH (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Amandine Everard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota
Jane L. Benjamin et al.
INFLAMMATORY BOWEL DISEASES (2012)
Nicotine as a potential neuroprotective agent for Parkinson's disease
Maryka Quik et al.
MOVEMENT DISORDERS (2012)
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
Pathological correlates of gastrointestinal dysfunction in Parkinson's disease
Maria G. Cersosimo et al.
NEUROBIOLOGY OF DISEASE (2012)
Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants
Ekaterina V. Khokhlova et al.
MICROBIOLOGY AND IMMUNOLOGY (2012)
Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins
Hui Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
Francisco Pan-Montojo et al.
SCIENTIFIC REPORTS (2012)
Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson's disease in rats
Mikako Ito et al.
MEDICAL GAS RESEARCH (2012)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Karin Wirdefeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2010)
Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria
Chin Wen Png et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms
Rui D. S. Prediger
JOURNAL OF ALZHEIMERS DISEASE (2010)
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Andre Franke et al.
NATURE GENETICS (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
Clinical availability of skin biopsy in the diagnosis of Parkinson's disease
Yasuo Miki et al.
NEUROSCIENCE LETTERS (2010)
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Francisco Pan-Montojo et al.
PLOS ONE (2010)
Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease
Kenichi Kashihara et al.
PARKINSONISM & RELATED DISORDERS (2010)
Intestinal hormones and regulation of satiety: The case for CCK, GLP-1, PYY, and Apo A-IV
David D'Alessio
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2008)
Parkinson's disease: a dual-hit hypothesis
C. H. Hawkes et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
B. F. Boeve et al.
BRAIN (2007)
Dietary intake in relation to self-reported constipation among Japanese women aged 18-20 years
K Murakami et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2006)
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2005)
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation
IL Khalif et al.
DIGESTIVE AND LIVER DISEASE (2005)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Antioxidant properties of ursodeoxycholic acid
D Lapenna et al.
BIOCHEMICAL PHARMACOLOGY (2002)
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
MA Hernán et al.
ANNALS OF NEUROLOGY (2002)
Smoking and Parkinson's disease in twins
CM Tanner et al.
NEUROLOGY (2002)
Frequency of bowel movements and the future risk of Parkinson's disease
RD Abbott et al.
NEUROLOGY (2001)
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro
D Casper et al.
NEUROSCIENCE LETTERS (2000)